Biogen (NASDAQ:BIIB) Earns Hold Rating from Needham & Company LLC
Needham & Company LLC reaffirmed their hold rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report report published on Wednesday,Benzinga reports. A number of other research analysts also recently commented on BIIB. Wells Fargo & Company cut their target price on shares of Biogen from $165.00 to $140.00 and set an […]
Needham & Company LLC reaffirmed their hold rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report report published on Wednesday,Benzinga reports. A number of other research analysts also recently commented on BIIB. Wells Fargo & Company cut their target price on shares of Biogen from $165.00 to $140.00 and set an […]